---
figid: PMC5707070__oncotarget-08-95914-g008
figtitle: Alpha-Tocopherol prevents esophageal squamous cell carcinoma by modulating
  PPARGamma-Akt signaling pathway at the early stage of carcinogenesis
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Capra hircus
- Homo sapiens
- Meleagris gallopavo
organisms_ner:
- Bos taurus
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Capra hircus
- Meleagris gallopavo
- Drosophila melanogaster
- Danio rerio
pmcid: PMC5707070
filename: oncotarget-08-95914-g008.jpg
figlink: /pmc/articles/PMC5707070/figure/F8/
number: F8
caption: (1) NMBA induces Akt activation in esophageal epithelium cells, resulting
  in the acceleration of cell cycle and the inhibition of apoptosis. (2) At the early
  stage of carcinogenesis, α-Tocopherol effectively increases the expression of PPARγ
  and PTEN, which attenuated the activation of Akt signaling pathway leading to cell
  cycle arrest and enhanced cell apoptosis. α-Tocopherol is effective in ESCC prevention
  during this stage. (3) As the pathologic lesions progressed (late stage), PPARγ
  and Akt become constitutively activated and insensitive to α-Tocopherol. Supplementation
  with α-Tocopherol at this stage is not effective for ESCC prevention.
papertitle: Alpha-Tocopherol prevents esophageal squamous cell carcinoma by modulating
  PPARγ-Akt signaling pathway at the early stage of carcinogenesis.
reftext: Miao Xu, et al. Oncotarget. 2017 Nov 10;8(56):95914-95930.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9619993
figid_alias: PMC5707070__F8
figtype: Figure
redirect_from: /figures/PMC5707070__F8
ndex: 61f2e5c5-dea5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5707070__oncotarget-08-95914-g008.html
  '@type': Dataset
  description: (1) NMBA induces Akt activation in esophageal epithelium cells, resulting
    in the acceleration of cell cycle and the inhibition of apoptosis. (2) At the
    early stage of carcinogenesis, α-Tocopherol effectively increases the expression
    of PPARγ and PTEN, which attenuated the activation of Akt signaling pathway leading
    to cell cycle arrest and enhanced cell apoptosis. α-Tocopherol is effective in
    ESCC prevention during this stage. (3) As the pathologic lesions progressed (late
    stage), PPARγ and Akt become constitutively activated and insensitive to α-Tocopherol.
    Supplementation with α-Tocopherol at this stage is not effective for ESCC prevention.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - BAD
  - BAX
  - MDM2
  - BCL2
  - PTEN
  - CDK1
  - CDKN1A
  - Akt1
  - Bad
  - Bax
  - Nkx3-1
  - Mdm2
  - Bcl2
  - Pten
  - Trp53
  - Cdk1
  - Cdc2b
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Gabrg2
  - AKT2
  - AKT3
  - TP53
  - TP63
  - TP73
  - POLD1
  - TCEAL1
  - NSG1
  - H3P16
  - WARS1
  - Tp53
  - Ccne1
  - Kras
  - P21
  - lds
  - Akt
  - cass
  - Debcl
  - p53
  - betaTub60D
  - hth
  - fzy
  - CycE
  - cyc
  - dap
  - anon-70Dc
  - nmba
  - badb
  - baxa
  - mdm2
  - chmp2a
  - ptenb
  - tp53
  - cdk1
  - cdkn1a
  - Cancer
---
